Stock Analysis on Net
Stock Analysis on Net

GlaxoSmithKline PLC (NYSE:GSK)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 27, 2015.

Common-Size Balance Sheet: Assets

Paying users area

Try for free

GlaxoSmithKline PLC pages available for free this week:

The data is hidden behind: . Unhide it.

  • Get 1-month access to GlaxoSmithKline PLC for $22.49, or

  • get full access to the entire website for at least 3 months from $62.19.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

GlaxoSmithKline PLC, common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Property, plant and equipment
Goodwill
Other intangible assets
Joint ventures
Associated
Investments in associates and joint ventures
Other investments
Deferred tax assets
Derivative financial instruments
Amounts receivable under insurance contracts
Pension schemes in surplus
Other receivables
Other non-current assets
Non-current assets
Inventories
Current tax recoverable
Trade receivables, net of provision for bad and doubtful debts
Prepaid pension contributions
Other prepayments and accrued income
Interest receivable
Employee loans and advances
Other receivables
Trade and other receivables
Derivative financial instruments
Liquid investments
Cash and cash equivalents
Assets held for sale
Current assets
Total assets

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

Balance sheet item Description The company
Property, plant and equipment Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. GlaxoSmithKline PLC property, plant and equipment as a percentage of total assets decreased from 2012 to 2013 but then increased from 2013 to 2014 exceeding 2012 level.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. GlaxoSmithKline PLC non-current assets as a percentage of total assets decreased from 2012 to 2013 but then slightly increased from 2013 to 2014.
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. GlaxoSmithKline PLC current assets as a percentage of total assets increased from 2012 to 2013 but then slightly decreased from 2013 to 2014.